July 10 (Reuters) – Fusen Pharmaceutical Co Ltd: * DOXAZOSIN MESYLATE EXTENDED-RELEASE TABLETS APPROVED FOR MARKETING IN CHINA Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
China to monitor US tariff measures, reserves right to act, commerce ministry says
BEIJING, Aug 27 (Reuters) - China will continue to monitor and assess U.S. moves, the…
Poland asks EU to fine Meta €250 million, urges action against scams and false ads
WARSAW, Aug 27 (Reuters) - Poland's Minister of Digital Affairs said on Wednesday he had…
Meta settlement opens new front in global fight over social media harm
By Byron Kaye and Karen Lema SYDNEY/MANILA, Aug 27 (Reuters) - Meta's move to restrict…
